Annukka Vahtera Selected Research

Annukka Vahtera Research Topics

3	Critical Illness (Critically Ill) 01/2021 - 03/2016
1	COVID-19 10/2020
1	Shock 10/2020
1	Pneumonia (Pneumonitis) 12/2018
1	Human Influenza (Influenza) 12/2018
1	Thrombocytopenia (Thrombopenia) 12/2018
1	Venous Thromboembolism 03/2016

2	Enoxaparin (Lovenox)FDA LinkGeneric 01/2021 - 10/2017
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 12/2018 - 03/2016
1	Thrombin FDA Link 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2020
1	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2020
1	Heparin (Liquaemin)FDA LinkGeneric 12/2018
1	Biomarkers (Surrogate Marker)IBA 03/2016

2	Intravenous Infusions 01/2021 - 10/2017
1	Critical Care (Surgical Intensive Care) 03/2016